CGDV
DividendCapital Group Dividend Value ETF
Capital Group · Tracks (actively managed — no index) · Inception Feb 22, 2022
Composite score
Based on a 0.33% expense ratio.
Based on $37.16B in net assets.
Top-10 holdings represent 40.1% of net assets.
Dividend base · ETF wrapper · 1.19% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use CGDV in our tools
Tool · Cost
Compare CGDV's fee against another fund
Compounds the 0.33% expense ratio against a peer over decades.
Tool · Overlap
Compare CGDV's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Dividend funds.
Tool · TLH
Find a tax-loss harvesting partner for CGDV
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Microsoft Corp | 5.37% |
| 2 | NVIDIA Corp | 5.04% |
| 3 | RTX Corp | 4.43% |
| 4 | Broadcom Inc | 4.30% |
| 5 | Applied Materials Inc | 4.23% |
| 6 | Carrier Global Corp | 3.61% |
| 7 | General Electric Co | 3.42% |
| 8 | British American Tobacco PLC | 3.40% |
| 9 | Eli Lilly & Co | 3.33% |
| 10 | Meta Platforms Inc | 2.96% |
Compare CGDV with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open CGDV at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.